Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Xiaochen Li1,2, Shuyun Xu1,2, Muqing Yu1,2, Ke Wang1,2, Yu Tao1,2, Ying Zhou1,2, Jing Shi1,2, Min Zhou1,2, Bo Wu3, Zhenyu Yang1,2, Cong Zhang1,2, Junqing Yue1,2, Zhiguo Zhang4, Harald Renz5, Xiansheng Liu1,2, Jungang Xie1,2, Min Xie1,2, Jianping Zhao1,2
1Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Key Laboratory of Respiratory Diseases, National Ministry of Health of the People’s Republic of China and National Clinical Research Center for Respiratory Disease, Wuhan, China
3United Imaging Healthcare Co Ltd, Wuhan, China
4School of Medicine and Health Management, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics Philipps University Marburg, University Hospital Giessen and Marburg GmbH, Marburg, Germany.
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Allergy and Clinical Immunology
Tập 146
110-118
Thông tin tác giả